http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1866335-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f85af810578fac3d697eb58690a6f7c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70571 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
| filingDate | 2006-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2552a69c398913ef7cee95169fcfb591 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1acb701543df18416ba34c8840dd837 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a77a4af6d01c2c0051f49a6c7a87cb4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d272f4c49e0406d6f3670fea203ece8 |
| publicationDate | 2007-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1866335-A2 |
| titleOfInvention | MEANS FOR THE INHIBITION OF ANTI- ß1-ADRENERGIC RECEPTOR ANTIBODIES |
| abstract | The present invention is related to a peptide selected from the group comprising a) a cyclic peptide of formula (I): Cyclo(AIa-x-x-x-x-x-x-x-x-x-Cys-x-x-x-Pro-x-Cys-Cys-xk-GIn), (I) whereby k is any integer from 0 to 6, preferably any integer from 1 to 6, more preferably k = 6; b) a cyclic peptide of formula (II): Cyclo(Ala-x-x-Trp-x-x-Gly-x-Phe-x-Cys-xh-Gln), (II) whereby h is any integer from 0 to 2, preferably 1 or 2; c) a cyclic peptide of formula (III): Cyclo(AIa-x-x-x-x-x-x-x-x-x-Cys-xj-Cys-x-x-x-Pro-x-Cys-Cys-xi-Gln); (HI) whereby j is any integer from 0 to 4, preferably j = 4; whereby i is any integer from 0 to 6, preferably any integer from 1 to 6, more preferably i - 6; and d) a peptide of formula (IV) : Ala-xl-Cys-xm-Cys-x-x-x-Pro-x-Cys-Cys-xn-Gln, (IV) whereby 1 is any integer from 0 to 9, preferably any integer from 1 to 9, more preferably n = 9; whereby m is any integer from 0 to 4, preferably any integer from 1 to 4, more preferably m = 4; whereby n is any integer from O to 6, preferably any integer from 1 to 6, more preferably n = 6; whereby x is any amino acid, preferably any naturally occurring amino acid, more preferably any naturally occurring L-amino acid. |
| priorityDate | 2005-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 245.